These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33615986)

  • 1. Treatment Exit Options for Non-infectious Uveitis (TOFU): Study Protocol for a Prospective Clinical Registry.
    Li JQ; Heinz C; Dell J; Schmid M; Finger RP
    Ophthalmic Epidemiol; 2022 Feb; 29(1):31-38. PubMed ID: 33615986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Treatment Exit Options for Uveitis (TOFU) Registry: Involving Patients in the Generation of Evidence].
    Li JQ; Dell J; Höller T; Fink D; Schmid M; Heinz C; Finger RP
    Gesundheitswesen; 2021 Nov; 83(S 01):S39-S44. PubMed ID: 34731892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment exit options for non-infectious uveitis registry: participant characteristics at 3 years.
    Fink DJ; Dell J; Heinz C; Wintergerst MWM; Höller T; Berger M; Schmid M; Boden KT; Pleyer U; Reitsamer H; Deuter CME; Lohmann TK; Finger RP;
    Br J Ophthalmol; 2024 Jun; ():. PubMed ID: 38857972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveitis Registries - A Digital Tool for Patient Care, Education, Research, and Collaboration.
    Zhang Z; Ng Ming Sheng S; Kempen JH; Fabiani C; Arora A; Gupta V; Tsui E; Cimino L; Symes RJ; Dell J; Finger RP; Heinz C; Agrawal R
    Ocul Immunol Inflamm; 2023 Nov; 31(9):1859-1869. PubMed ID: 36328530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uveitis treated with biotherapy and/or DMARD: Analysis from the French Pharmacovigilance Study Base].
    Cabane L; Baillif S; Baldin B; Breuil V; Euller-Ziegler L; Tieulié N
    J Fr Ophtalmol; 2018 Apr; 41(4):350-356. PubMed ID: 29656829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of conventional immunosuppressive drugs versus anti-TNF-α agents in non-infectious non-anterior uveitis.
    Leclercq M; Langlois V; Girszyn N; Le Besnerais M; Benhamou Y; Levesque H; Muraine M; Gueudry J
    J Autoimmun; 2020 Sep; 113():102481. PubMed ID: 32586650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Henderson LA; Zurakowski D; Angeles-Han ST; Lasky A; Rabinovich CE; Lo MS;
    Pediatr Rheumatol Online J; 2016 Feb; 14(1):9. PubMed ID: 26879972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveitis in Juvenile Idiopathic Arthritis - Case Reports on Guideline-based Diagnostic Work-up and Treatment.
    Heiligenhaus A; Deuter C
    Klin Monbl Augenheilkd; 2022 May; 239(5):676-685. PubMed ID: 35320873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic and Clinical Characteristics of Uveitis in Turkey: The First National Registry Report.
    Yalçındağ FN; Özdal PC; Özyazgan Y; Batıoğlu F; Tugal-Tutkun I;
    Ocul Immunol Inflamm; 2018; 26(1):17-26. PubMed ID: 27467500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group].
    Heiligenhaus A; Rothaus K; Pleyer U
    Ophthalmologe; 2021 Sep; 118(9):913-918. PubMed ID: 34459962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis.
    Miraldi Utz V; Bulas S; Lopper S; Fenchel M; Sa T; Mehta M; Ash D; Lovell DJ; Kaufman AH
    Pediatr Rheumatol Online J; 2019 Nov; 17(1):79. PubMed ID: 31783768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Development of a Web-Based Prospective Nationwide Registry for Ocular Inflammatory Diseases: UVEITE.PT - The Portuguese Ocular Inflammation Registry.
    Leal I; Nogueira V; Matos DB; Araújo J; Berens O; Ribeiro M; Furtado MJ; Liverani M; Silva MI; Guedes M; Cordeiro M; Ribeiro M; José P; Barão R; Nunes Ferreira R; Fonseca S; Mano S; Pina S; Santos MJ; Fonseca JE; Fonseca C; Figueira L
    Ocul Immunol Inflamm; 2024 Apr; 32(3):342-350. PubMed ID: 36780588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
    Zannin ME; Birolo C; Gerloni VM; Miserocchi E; Pontikaki I; Paroli MP; Bracaglia C; Shardlow A; Parentin F; Cimaz R; Simonini G; Falcini F; Corona F; Viola S; De Marco R; Breda L; La Torre F; Vittadello F; Martini G; Zulian F
    J Rheumatol; 2013 Jan; 40(1):74-9. PubMed ID: 23118110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease uveitis: is there a need for new emerging drugs?
    Tugal-Tutkun I; Çakar Özdal P
    Expert Opin Emerg Drugs; 2020 Dec; 25(4):531-547. PubMed ID: 33147420
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group.
    Llorenç V; Cordero-Coma M; Blanco-Esteban A; Heras-Mulero H; Losada-Castillo MJ; Jovani-Casano V; Valls-Pascual E; Jodar-Marquez M; García-Aparicio Á; Fonollosa A; González-Guijarro JJ; Rodriguez-Melian L; Fernández-Prada M; Jerez-Fidalgo M; Hernandez-Garfella M; Esquinas C; Sainz-de-la-Maza M; Adán A;
    Ophthalmology; 2020 Jun; 127(6):814-825. PubMed ID: 31952883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis.
    Casa FD; Vitale A; Guerriero S; Sota J; Cimaz R; Ragab G; Ruscitti P; Pereira RMR; Minoia F; Del Giudice E; Emmi G; Lomater C; Monti S; Canofari C; Gaggiano C; Alessio G; Miserocchi E; Conforti A; Dagostin MA; Mapelli C; Paroli MP; Parretti V; Albano V; Favale R; Marelli L; Hegazy MT; Cipriani P; Antonelli IPB; Caggiano V; Aragona E; Laymouna AH; Tosi GM; Tarsia M; Cattalini M; La Torre F; Lopalco G; Więsik-Szewczyk E; Frassi M; Gentileschi S; Giordano HF; Frediani B; Shinjo SK; Rigante D; Sfikakis PP; Balistreri A; Hussein MA; Amin RH; Cantarini L; Fabiani C;
    Ophthalmol Ther; 2022 Apr; 11(2):899-911. PubMed ID: 35099782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveitis in seronegative arthritis.
    Wendling D
    Curr Rheumatol Rep; 2012 Oct; 14(5):402-8. PubMed ID: 22736066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Registry-based research in ophthalmology].
    Li J; Heinz C; Finger RP
    Ophthalmologe; 2018 Oct; 115(10):826-831. PubMed ID: 29766264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis].
    Niehues T; Winterhalter S; Zierhut M; Michels H; Becker MD; Heiligenhaus A
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):520-5. PubMed ID: 17594624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current evidence of anti-tumor necrosis factor α treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs.
    Simonini G; Druce K; Cimaz R; Macfarlane GJ; Jones GT
    Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1073-84. PubMed ID: 24740981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.